GLP-1 receptor agonist use tied to higher NAION risk
Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modestly increased risk of nonarteritic ischemic optic neuropathy (NAION), according to data from a meta-analysis of more than 1.5 million patients presented at the 59th Annual Scientific Meeting of The Retina Society. The analysis included 15 longitudinal studies, 8 of which were randomized... ...